Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study

Cancer Epidemiol. 2017 Jun:48:158. doi: 10.1016/j.canep.2017.02.006. Epub 2017 Mar 11.

Authors

Úna Mc Menamin¹, Chris Cardwell², Carmel Hughes³, Liam Murray²

Affiliations

¹ Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom. Electronic address: u.mcmenamin@qub.ac.uk.
² Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
³ School of Pharmacy, Queen's University Belfast, Northern Ireland, United Kingdom.

PMID: 28291679
DOI: 10.1016/j.canep.2017.02.006

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal
Aspirin*
Breast Neoplasms*
Cohort Studies
Humans

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin

Grants and funding

20100/CRUK_/Cancer Research UK/United Kingdom